Key result
Multimodality imaging proves essential for accurate diagnosis, risk stratification, and management of HCM.
Why the study?
HCM management depends on early, accurate diagnosis, but lack of a definitive test, phenotypic variation, phenocopies, and normal left ventricular function make it reliant on multimethod imaging.
This review highlights the critical role of multimodality imaging in the comprehensive management and evaluation of hypertrophic cardiomyopathy.
Supports guideline-directed multimodality imaging in HCM; leaves optimal protocols and outcomes data open for prospective study.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Abraham et al. (2024) conducted a review in Hypertrophic cardiomyopathy (HCM). Multimethod imaging (echocardiography, CT, MRI, nuclear scanning) was evaluated. Multimethod imaging, including echocardiography, CT, MRI, and nuclear scanning, is essential for the accurate diagnosis, risk stratification, and management of hypertrophic cardiomyopathy.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: